000 01145 a2200337 4500
005 20250518053953.0
264 0 _c20200206
008 202002s 0 0 eng d
022 _a1879-0712
024 7 _a10.1016/j.ejphar.2019.172598
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHendriks, Anne M
245 0 0 _aSulfonylurea derivatives and cancer, friend or foe?
_h[electronic resource]
260 _bEuropean journal of pharmacology
_cOct 2019
300 _a172598 p.
_bdigital
500 _aPublication Type: Journal Article; Systematic Review
650 0 4 _aAnimals
650 0 4 _aCarcinogenesis
_xdrug effects
650 0 4 _aHumans
650 0 4 _aNeoplasms
_xchemically induced
650 0 4 _aRisk
650 0 4 _aSulfonylurea Compounds
_xchemistry
700 1 _aSchrijnders, Dennis
700 1 _aKleefstra, Nanne
700 1 _ade Vries, Elisabeth G E
700 1 _aBilo, Henk J G
700 1 _aJalving, Mathilde
700 1 _aLandman, Gijs W D
773 0 _tEuropean journal of pharmacology
_gvol. 861
_gp. 172598
856 4 0 _uhttps://doi.org/10.1016/j.ejphar.2019.172598
_zAvailable from publisher's website
999 _c30001638
_d30001638